Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05308979 · ClinicalTrials.gov registry record · Phase 4
Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial
A Phase 4 study of Overactive Bladder and Overactive Bladder Syndrome, sponsored by University of California, Irvine.
- Completed
- Registry status
- Phase 4
- Development phase
- 116
- Enrollment target
- 1
- Study location
NCT05308979 is a Phase 4 study of Overactive Bladder and Overactive Bladder Syndrome that has completed, run by University of California, Irvine. The registered enrollment target is 116 participants, below the 209-participant average among 45 other Overactive Bladder trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05308979, a Phase 4 study of Overactive Bladder and Overactive Bladder Syndrome, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 116 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with either overactive bladder (OAB) or urgency urinary incontinence (UUI) with be randomized (like a flip of a coin) to receive 100 units of bladder Botox® at either one injection site or ten injection sites. Efficacy and patient satisfaction will be measured by questionnaires.
Conditions Studied
Interventions
- DRUG OnabotulinumtoxinA 100 UNT [Botox]
Study Locations (1)
California
- University of California Irvine Medical Center - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2022-05-01 |
| Est. Completion | 2024-03-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05308979
The ClinicalTrials.gov registry entry for NCT05308979 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 209-participant average among 45 other Overactive Bladder trials with a reported enrollment target (44% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Overactive Bladder appearing as the primary indexed condition, and to 1 intervention - of which OnabotulinumtoxinA 100 UNT [Botox] is the first listed.
NCT05308979 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05308979 about?
NCT05308979 is a clinical study titled "Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial". Patients with either overactive bladder (OAB) or urgency urinary incontinence (UUI) with be randomized (like a flip of a coin) to receive 100 units of bladder Botox® at either one injection site or ten injection sites. Efficacy and patient satisfaction will be measured by questionnaires.
What is the current status of trial NCT05308979?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 116 participants. The study started on 2022-05-01. Estimated completion is 2024-03-31.
What conditions does trial NCT05308979 study?
This clinical trial studies the following conditions: Overactive Bladder, Overactive Bladder Syndrome, Urinary Incontinence, Urge, Urge Incontinence, Urinary Urge Incontinence.
What interventions are being tested in trial NCT05308979?
The interventions under investigation include: OnabotulinumtoxinA 100 UNT [Botox] (DRUG).
Who is sponsoring clinical trial NCT05308979?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05308979 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overactive Bladder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Bladder Botox UTI Antibiotic Prophylaxis
RECRUITING · Phase 4
-
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
RECRUITING · Phase 4
-
Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks
RECRUITING · Phase 4
-
TReating Incontinence for Underlying Mental and Physical Health
RECRUITING · Phase 4
-
Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder
COMPLETED · Phase 4
-
Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.